Edge Therapeutics, Inc. (extinct)

Edge Therapeutics, Inc. (extinct)

Edge Therapeutics, Inc. (extinct)

Overview
Date Founded

2009

Headquarters

300 Connell Drive,Suite 4000,Berkeley Heights, NJ 07922

Type of Company

Public

Employees (Worldwide)

11 - 50

Industries

Biotechnology
Hospitals & Patient Services
Pharmaceuticals
Medical Support Services

Company Description

Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.

Contact Data
Trying to get in touch with decision makers at Edge Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Edge Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Edge Therapeutics, Inc.
Recent Transactions
Details Hidden

Edge Therapeutics, Inc. purchases PDS Operating Corp.

Details Hidden

Edge Therapeutics, Inc. issued USD Common Stock

Details Hidden

Edge Therapeutics, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onEdge Therapeutics, Inc. raised money in a private placement transaction

Underwriter

Advised onEdge Therapeutics, Inc. issued USD Common Stock

Escrow Agent

Advised onEdge Therapeutics, Inc. issued USD Common Stock

Associate

Advised onEdge Therapeutics, Inc. purchases PDS Operating Corp.

Associate

Advised onEdge Therapeutics, Inc. purchases PDS Operating Corp.

Legal Advisor

Advised onEdge Therapeutics, Inc. purchases PDS Operating Corp.

Advisors & Consultants
Legal Advisor

Partner at Dechert LLP

Publicist

Professional at 6 Degrees

Investors
Details Hidden

BioMed Ventures is an active manager invests in life science industries companies. The firm focus on broad range sectors includes drug discovery, drug development, diagnostics, tools and medical devices. It provides financing for growth stage capital requirements.

Details Hidden

Sofinnova Investment Inc. invests in companies located in the US and Europe. The firm targets companies operating in the fields of health technology services and life science and has primarily focused on therapeutic drugs. They provides financing for early and later stage capital requirements with investment size ranges from $15 to $35 million. They invests in both private & public companies.

Details Hidden

CWGI is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach; (2) long-established, global research; (3) a multiple portfolio counselor system that combines teamwork with individual accountability; (4) experienced, long-tenured investment professionals; and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System wherein the assets of each fund are divided into smaller, more manageable portions. Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results and portfolio counselors are free to make their own decisions. Investment decisions are based on internal research.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Edge Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Edge Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Edge Therapeutics, Inc..